Skyepharma Inc - San Diego, California 92121

Skyepharma Inc is categorized under in San Diego, CA .

Business Name: Skyepharma Inc
Contact Person: Steve Thornton
Address: 10450 Science Center Drive, San Diego, California 92121
Phone Number: (858) 678-3950
Website Address: pacira.com
Annual Revenue (USD): Unknown
Founding Year: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 325412
Share This Business:
Related Businesses: Tioga Pharmaceuticals Inc - San Diego, CA 92121
Amplyx Pharmaceuticals Inc - San Diego, CA 92121
Depotech Corp - San Diego, CA 92121
Pacira Pharmaceuticals Inc - San Diego, CA 92121
Amylin Ohio LLC - San Diego, CA 92121
Conatus Pharmaceuticals Inc - San Diego, CA 92121
Novomedix - San Diego, CA 92121
Coda Therapeutics Inc - San Diego, CA 92121
Bioserv Corp - San Diego, CA 92121
Proprius Inc - San Diego, CA 92121
Arena Pharmaceuticals Inc - San Diego, CA 92121
Amaze Therapeutics - San Diego, CA 92121
Mirati Therapeutics - San Diego, CA 92121
Formex LLC - San Diego, CA 92121
Prometheus Rxdx Inc - San Diego, CA 92121
Neuropore Therapies - San Diego, CA 92121
Regulus Therapeutics Inc - San Diego, CA 92121
Phage Biotechnology Corporation - San Diego, CA 92121
Advanced Molecular Design Inc - San Diego, CA 92121
Epigen Biosciences Inc - San Diego, CA 92121

The company Skyepharma Inc provides BOTH services in the form of from its single location in California. 1 to 4 employees work for Skyepharma Inc, and the business now earns Unknown per annum.

Skyepharma Inc was launched in 2007 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 . To contact Skyepharma Inc, please call Steve Thornton with the phone number (858) 678-3950 or visit its single location at 10450 Science Center Drive in San Diego, California 92121.

The location of the single location can also be found using the coordinates 32.891843,-117.231534. Read more details about this business on the webpage pacira.com or follow the company’s social media accounts, on Twitter and on Facebook.